Zhitong Finance App News, Xinlitai (002294.SZ) issued an announcement. Recently, according to the repurchase terms agreed in the original agreement, since Xintai Medical did not achieve a qualified initial public offering within the agreed period of the agreement, the company plans to fulfill the share repurchase obligation as agreed and sign a “Transfer Agreement” with the investor. As agreed, the company will use its own capital of RMB 427 million to repurchase a total of 6.1424% of Xintai Healthcare's shares held by investors. After the repurchase is completed, the company's shareholding ratio in Xintai Healthcare will increase from 87.3639% to 93.5063%.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.